Optimal duration of dual antiplatelet therapy (DAPT) after stent implantation is uncertain. Some patients have an extended risk of thrombotic complications including that of very late stent thrombosis after cessation of recommended course of DAPT (6-12 months). On the other hand, there is a real risk of bleeding on DAPT. In this review, we present and discuss results of clinical trials of long-term DAPT and data of their meta-analyses. The review also contains consideration of some aspects of new AHA/ACC recommendations (2016) on duration of DAPT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.18087/cardio.2018.1.10081 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!